rtki cpd has been researched along with Acute Liver Injury, Drug-Induced in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, C; Isse, K; Li, G; Lim, K; Wu, T; Xu, L | 1 |
| Chen, W; Han, C; Li, G; Wu, T | 1 |
2 other study(ies) available for rtki cpd and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
Cyclooxygenase-2 prevents fas-induced liver injury through up-regulation of epidermal growth factor receptor.
Topics: Animals; Apoptosis; Chemical and Drug Induced Liver Injury; Cyclooxygenase 2; ErbB Receptors; fas Receptor; Fas-Associated Death Domain Protein; Hepatocytes; Liver; Liver Failure; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Nitrobenzenes; Quinazolines; Sulfonamides; Tyrphostins; Up-Regulation | 2009 |
Cytosolic phospholipase A(2)α protects against Fas- but not LPS-induced liver injury.
Topics: Animals; Apoptosis; Caspases; Chemical and Drug Induced Liver Injury; ErbB Receptors; fas Receptor; Female; Galactosamine; Gene Expression; Group IV Phospholipases A2; Hepatocytes; Humans; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Quinazolines; Recombinant Proteins; Tyrphostins | 2011 |